REGENXBIO Inc. Net Cash Provided by (Used in) Financing Activities in USD from 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
REGENXBIO Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to Q1 2025.
  • REGENXBIO Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$5.79M, a 105% decline year-over-year.
  • REGENXBIO Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $92.7M.
  • REGENXBIO Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$35M, a 21.2% decline from 2022.
  • REGENXBIO Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$28.8M, a 115% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

REGENXBIO Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$5.79M -$127M -105% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q1 2024 $121M +$130M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q1 2023 -$9.04M -$2.2M -32.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 -$6.83M -$218M -103% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $211M +$209M +7553% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $2.76M -$1.37M -33.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $4.13M -$39K -0.94% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $4.17M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07

REGENXBIO Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $92.7M +$128M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 -$35M -$6.13M -21.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 -$28.8M -$224M -115% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-13
2021 $195M -$4.96M -2.48% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $200M +$192M +2290% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $8.38M -$196M -95.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $204M +$120M +142% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $84.6M +$84.5M +70991% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $119K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.